118 related articles for article (PubMed ID: 24517327)
1. Assessing the essentiality of the decaprenyl-phospho-d-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants.
Kolly GS; Boldrin F; Sala C; Dhar N; Hartkoorn RC; Ventura M; Serafini A; McKinney JD; Manganelli R; Cole ST
Mol Microbiol; 2014 Apr; 92(1):194-211. PubMed ID: 24517327
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy.
Wolucka BA
FEBS J; 2008 Jun; 275(11):2691-711. PubMed ID: 18422659
[TBL] [Abstract][Full Text] [Related]
3. Assessing essentiality of transketolase in Mycobacterium tuberculosis using an inducible protein degradation system.
Kolly GS; Sala C; Vocat A; Cole ST
FEMS Microbiol Lett; 2014 Sep; 358(1):30-5. PubMed ID: 25047872
[TBL] [Abstract][Full Text] [Related]
4. DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization.
Brecik M; Centárová I; Mukherjee R; Kolly GS; Huszár S; Bobovská A; Kilacsková E; Mokošová V; Svetlíková Z; Šarkan M; Neres J; Korduláková J; Cole ST; Mikušová K
ACS Chem Biol; 2015 Jul; 10(7):1631-6. PubMed ID: 25906160
[TBL] [Abstract][Full Text] [Related]
5. The effect of MSMEG_6402 gene disruption on the cell wall structure of Mycobacterium smegmatis.
Jiang T; He L; Zhan Y; Zang S; Ma Y; Zhao X; Zhang C; Xin Y
Microb Pathog; 2011 Sep; 51(3):156-60. PubMed ID: 21575707
[TBL] [Abstract][Full Text] [Related]
6. GtrA Protein Rv3789 Is Required for Arabinosylation of Arabinogalactan in Mycobacterium tuberculosis.
Kolly GS; Mukherjee R; Kilacsková E; Abriata LA; Raccaud M; Blaško J; Sala C; Dal Peraro M; Mikušová K; Cole ST
J Bacteriol; 2015 Dec; 197(23):3686-97. PubMed ID: 26369580
[TBL] [Abstract][Full Text] [Related]
7. Functional identification of MSMEG_6402 protein from Mycobacterium smegmatis in decaprenylphosphoryl-D-arabinose biosynthesis.
Jiang T; Cai L; Zhao X; He L; Ma Y; Zang S; Zhang C; Li X; Xin Y
Microb Pathog; 2014 Nov; 76():44-50. PubMed ID: 25223716
[TBL] [Abstract][Full Text] [Related]
8. Benzothiazinones mediate killing of Corynebacterineae by blocking decaprenyl phosphate recycling involved in cell wall biosynthesis.
Grover S; Alderwick LJ; Mishra AK; Krumbach K; Marienhagen J; Eggeling L; Bhatt A; Besra GS
J Biol Chem; 2014 Feb; 289(9):6177-87. PubMed ID: 24446451
[TBL] [Abstract][Full Text] [Related]
9. Conditional silencing of topoisomerase I gene of Mycobacterium tuberculosis validates its essentiality for cell survival.
Ahmed W; Menon S; Godbole AA; Karthik PV; Nagaraja V
FEMS Microbiol Lett; 2014 Apr; 353(2):116-23. PubMed ID: 24593153
[TBL] [Abstract][Full Text] [Related]
10. Decaprenylphosphoryl-β-D-ribose 2'-epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in Mycobacterium smegmatis.
Crellin PK; Brammananth R; Coppel RL
PLoS One; 2011 Feb; 6(2):e16869. PubMed ID: 21346818
[TBL] [Abstract][Full Text] [Related]
11. Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.
Bhutani I; Loharch S; Gupta P; Madathil R; Parkesh R
PLoS One; 2015; 10(3):e0119771. PubMed ID: 25789990
[TBL] [Abstract][Full Text] [Related]
12. Assay development and inhibition of the
Batt SM; Toth S; Rodriguez B; Abrahams KA; Veerapen N; Chiodarelli G; Cox LR; Moynihan PJ; Lelievre J; Fütterer K; Besra GS
Microbiology (Reading); 2023 Jan; 169(1):. PubMed ID: 36748627
[TBL] [Abstract][Full Text] [Related]
13. Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art.
Buroni S; Pasca MR; de Jesus Lopes Ribeiro AL; Degiacomi G; Molteni E; Riccardi G
Appl Microbiol Biotechnol; 2012 May; 94(4):907-16. PubMed ID: 22526781
[TBL] [Abstract][Full Text] [Related]
14. Structure based pharmacophore modelling approach for the design of azaindole derivatives as DprE1 inhibitors for tuberculosis.
Kb S; Kumari A; Shetty D; Fernandes E; Dv C; Jays J; Murahari M
J Mol Graph Model; 2020 Dec; 101():107718. PubMed ID: 32949960
[TBL] [Abstract][Full Text] [Related]
15. The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis.
Riccardi G; Pasca MR; Chiarelli LR; Manina G; Mattevi A; Binda C
Appl Microbiol Biotechnol; 2013 Oct; 97(20):8841-8. PubMed ID: 24037308
[TBL] [Abstract][Full Text] [Related]
16. Structural analysis of phosphoribosyltransferase-mediated cell wall precursor synthesis in Mycobacterium tuberculosis.
Gao S; Wu F; Gurcha SS; Batt SM; Besra GS; Rao Z; Zhang L
Nat Microbiol; 2024 Apr; 9(4):976-987. PubMed ID: 38491273
[TBL] [Abstract][Full Text] [Related]
17. Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis.
Ribeiro AL; Degiacomi G; Ewann F; Buroni S; Incandela ML; Chiarelli LR; Mori G; Kim J; Contreras-Dominguez M; Park YS; Han SJ; Brodin P; Valentini G; Rizzi M; Riccardi G; Pasca MR
PLoS One; 2011; 6(11):e26675. PubMed ID: 22069462
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set.
Sun R; Converse PJ; Ko C; Tyagi S; Morrison NE; Bishai WR
Mol Microbiol; 2004 Apr; 52(1):25-38. PubMed ID: 15049808
[TBL] [Abstract][Full Text] [Related]
19. Identifying vulnerable pathways in Mycobacterium tuberculosis by using a knockdown approach.
Carroll P; Faray-Kele MC; Parish T
Appl Environ Microbiol; 2011 Jul; 77(14):5040-3. PubMed ID: 21642404
[TBL] [Abstract][Full Text] [Related]
20. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
